Restriction of Viral Membrane Fusion and Entry by IFITM Proteins
Restriction of Viral Membrane Fusion and Entry by IFITM Proteins
批准号:
8896142
负责人:
Shan-Lu Liu
金额:
$39.3万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-04 至 2016-07-31
关键词:
AdoptedAffectAmino AcidsAntiviral AgentsAntiviral TherapyApplications GrantsBiochemicalBiological ModelsBiophysical ProcessCell fusionCell membraneCellsCellular biologyCholesterolConsensusDevelopmentEbola virusEventFluorescenceFluorescent DyesGoalsGrowthHIV-1HealthHumanIFITM1 geneImageImaging TechniquesImmunityInfectionInfluenza A virusIntegral Membrane ProteinInterferonsKnowledgeLabelLeadLipidsMeasuresMechanicsMediatingMembraneMembrane FluidityMembrane FusionMicroscopyMolecularMolecular BiologyOrthologous GenePeptidesPost-Translational Protein ProcessingProcessPropertyReportingResearchRetroviridaeRoleSARS coronavirusSemliki forest virusSevere Acute Respiratory SyndromeStagingTestingTherapeutic AgentsTherapeutic InterventionTyrosine PhosphorylationUbiquitinationViralViral Fusion ProteinsVirusVirus DiseasesWorkbasedesigninhibitor/antagonistnovelnovel strategiesnovel therapeuticsresearch studyvesicular stomatitis virus G protein
中文摘要
描述(由申请人提供):我们研究的长期目标是更好地了解病毒进入的机制和可能对治疗干预的影响。为了实现这些目标,我们最近研究了干扰素诱导的跨膜蛋白(IFITM),它可以有效地抑制多种病毒的进入和感染,包括高致病性甲型流感病毒(IAV)、SARS冠状病毒、埃博拉病毒(EBOV)和HIV-1。我们发现IFITM蛋白深刻地抑制了IAV HA、Semliki森林病毒(SFV)E1和水疱性口炎病毒(VSV)G蛋白诱导的细胞-细胞融合,这些蛋白分别代表I、II和III类病毒融合蛋白。进一步的实验表明,IFITM阻止了病毒膜半融合的产生,这与它们降低膜流动性的能力是一致的。有趣的是,我们观察到一些病毒比其他病毒对特定类型的IFITM的抑制更敏感,这表明
IFITM介导的限制病毒进入的机制除了广泛的抑制作用外,还可以依赖于病毒。本项目的具体目标是(1)确定IFITM抑制病毒膜融合的分子和生物物理机制;(2)了解IFITM蛋白改变脂质性质和膜机制从而抑制病毒膜融合的分子基础;(3)阐明IFITM不同抗病毒活性的分子和细胞调控机制。总体而言,了解这项工作中提出的IFITM的潜在机制将极大地促进我们对干扰素介导的针对病毒入侵的内在免疫的了解。拟议的实验结果将有助于开发针对病毒感染的新型治疗剂。
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of our research is to better understand the mechanisms of viral entry and the possible implications for therapeutic interventions. To achieve these goals, we have recently studied the interferon-inducible transmembrane (IFITM) proteins that potently inhibit entry and infection of a wide range of viruses, including those of the highly pathogenic influenza A virus (IAV), SARS coronavirus, Ebolavirus (EBOV), and HIV-1. We showed that IFITM proteins profoundly inhibit cell-cell fusion induced by IAV HA, Semliki Forest virus (SFV) E1, and vesicular stomatitis virus (VSV) G proteins, which represent class I, II and III viral fusion proteins, respectively. Further experiments revealed that IFITMs block the creation of viral membrane hemifusion, which is consistent with their ability to decrease membrane fluidity. Interestingly, we observed that some viruses are more sensitive than others to inhibition by particular types of IFITMs, suggesting that
IFITM-mediated restriction of viral entry can, in addition to broad inhibitions, be virus dependent The specific aims of this project are (1) to determine the molecular and biophysical mechanisms by which IFITMs inhibit viral membrane fusion, (2) to understand the molecular basis by which IFITM proteins change lipid properties and membrane mechanics, thereby inhibiting viral membrane fusion, and (3) to elucidate the molecular and cellular control mechanisms that govern the differential antiviral activities of IFITMs. Collectively, understanding the underlying mechanisms of IFITMs as proposed in this work will significantly advance our knowledge of IFN-mediated intrinsic immunity against viral entry. Results from the proposed experiments will aid the development of novel therapeutic agents against viral infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
-
批准号:10242695
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2018
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:9376203
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2017
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:8991472
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
-
批准号:8730947
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Inhibition of Ebolavirus Entry by IFITM2 Protein
-
批准号:8702561
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2014
-
负责人:Shan-Lu Liu
-
依托单位:
Novel Cellular Factors Restricting Viral Membrane Fusion
-
批准号:8492736
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2013
-
负责人:Shan-Lu Liu
-
依托单位:
Novel Cellular Factors Restricting Viral Membrane Fusion
-
批准号:8605170
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2013
-
负责人:Shan-Lu Liu
-
依托单位:
海外基金